Introduction to Ramiven (Abemaciclib)
Ramiven is a medication manufactured by Eli Lilly and Company India Pvt Ltd. It contains the active ingredient Abemaciclib and is available in a strength of 100mg. Ramiven is specifically formulated for the treatment of Breast Cancer.
Uses of Ramiven
Ramiven is indicated for the treatment of Breast Cancer, providing therapeutic support in managing this challenging condition.
Benefits of Ramiven
This medication offers the benefit of potentially slowing down the progression of Breast Cancer and improving overall outcomes when used as part of a comprehensive treatment plan.
Mechanism of Action of Ramiven
Ramiven, containing Abemaciclib, belongs to a class of drugs known as cyclin-dependent kinase inhibitors. It works by blocking proteins that promote the growth of cancer cells, thereby helping to inhibit their proliferation and spread.